ANVS
Price
$5.01
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
69.12M
79 days until earnings call
MDGL
Price
$293.64
Change
+$20.85 (+7.64%)
Updated
Jan 17 closing price
Capitalization
6.4B
38 days until earnings call
Ad is loading...

ANVS vs MDGL

Header iconANVS vs MDGL Comparison
Open Charts ANVS vs MDGLBanner chart's image
Annovis Bio
Price$5.01
Change-$0.00 (-0.00%)
Volume$233.86K
Capitalization69.12M
Madrigal Pharmaceuticals
Price$293.64
Change+$20.85 (+7.64%)
Volume$866.12K
Capitalization6.4B
ANVS vs MDGL Comparison Chart
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. MDGL commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Hold and MDGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ANVS: $5.01 vs. MDGL: $293.64)
Brand notoriety: ANVS and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 63% vs. MDGL: 221%
Market capitalization -- ANVS: $69.12M vs. MDGL: $6.4B
ANVS [@Biotechnology] is valued at $69.12M. MDGL’s [@Biotechnology] market capitalization is $6.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 1 green FA rating(s).

  • ANVS’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than ANVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 4 TA indicator(s) are bullish while MDGL’s TA Score has 3 bullish TA indicator(s).

  • ANVS’s TA Score: 4 bullish, 3 bearish.
  • MDGL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than MDGL.

Price Growth

ANVS (@Biotechnology) experienced а +2.45% price change this week, while MDGL (@Biotechnology) price change was -13.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ANVS is expected to report earnings on May 08, 2025.

MDGL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($6.4B) has a higher market cap than ANVS($69.1M). ANVS YTD gains are higher at: -0.398 vs. MDGL (-4.838). ANVS has higher annual earnings (EBITDA): -30.4M vs. MDGL (-502.65M). MDGL has more cash in the bank: 999M vs. ANVS (12.6M). MDGL has higher revenues than ANVS: MDGL (76.8M) vs ANVS (0).
ANVSMDGLANVS / MDGL
Capitalization69.1M6.4B1%
EBITDA-30.4M-502.65M6%
Gain YTD-0.398-4.8388%
P/E RatioN/AN/A-
Revenue076.8M-
Total Cash12.6M999M1%
Total DebtN/A119M-
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
30
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANVSMDGL
RSI
ODDS (%)
Bullish Trend 12 days ago
79%
Bearish Trend 12 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 12 days ago
76%
MACD
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 12 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 12 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
76%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 20 days ago
81%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
71%
Aroon
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 12 days ago
79%
View a ticker or compare two or three
Ad is loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XMMO129.690.58
+0.45%
Invesco S&P MidCap Momentum ETF
LGOV20.810.04
+0.19%
First Trust Long Duration Opp ETF
SIO25.460.04
+0.17%
Touchstone Strategic Income ETF
FLSW32.740.03
+0.09%
Franklin FTSE Switzerland ETF
JHDV35.26N/A
N/A
JHancock U.S. High Dividend ETF

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
N/A
ADXN - ANVS
37%
Loosely correlated
+0.25%
MDGL - ANVS
36%
Loosely correlated
+7.64%
EWTX - ANVS
33%
Poorly correlated
-1.72%
VTYX - ANVS
32%
Poorly correlated
+6.88%
AXON - ANVS
31%
Poorly correlated
+1.37%
More